Why Vitruvias’ thyroid tablet recall comes at a sensitive moment for animal-derived thyroid medicines
Vitruvias Therapeutics is recalling one nationwide lot of 30 mg Thyroid Tablets after testing found potential superpotency, highlighting the narrow dosing margins of thyroid hormone replacement.